1
|
Krueger K, Catanese L, Sciesielski LK, Kirschner KM, Scholz H. Deletion of an intronic HIF-2α binding site suppresses hypoxia-induced WT1 expression. BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS 2018; 1862:71-83. [PMID: 30468780 DOI: 10.1016/j.bbagrm.2018.11.003] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/20/2018] [Revised: 11/02/2018] [Accepted: 11/18/2018] [Indexed: 12/20/2022]
Abstract
Hypoxia-inducible factors (HIFs) play a key role in the adaptation to low oxygen by interacting with hypoxia response elements (HREs) in the genome. Cellular levels of the HIF-2α transcription factor subunit influence the histopathology and clinical outcome of neuroblastoma, a malignant childhood tumor of the sympathetic ganglia. Expression of the Wilms tumor gene, WT1, marks a group of high-risk neuroblastoma. Here, we identify WT1 as a downstream target of HIF-2α in Kelly neuroblastoma cells. In chromatin immunoprecipitation assays, HIF-2α bound to a HRE in intron 3 of the WT1 gene, but not to another predicted HIF binding site (HBS) in the first intron. The identified element conferred oxygen sensitivity to otherwise hypoxia-resistant WT1 and SV40 promoter constructs. Deletion of the HBS in the intronic HRE by genome editing abolished WT1 expression in hypoxic neuroblastoma cells. Physical interaction between the HRE and the WT1 promoter in normoxic and hypoxic Kelly cells was shown by chromosome conformation capture assays. These findings demonstrate that binding of HIF-2α to an oxygen-sensitive enhancer in intron 3 stimulates transcription of the WT1 gene in neuroblastoma cells by hypoxia-independent chromatin looping. This novel regulatory mechanism may have implications for the biology and prognosis of neuroblastoma.
Collapse
Affiliation(s)
- Katharina Krueger
- Institut für Vegetative Physiologie, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany
| | - Lorenzo Catanese
- Institut für Vegetative Physiologie, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany
| | - Lina K Sciesielski
- Klinik für Neonatologie, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany
| | - Karin M Kirschner
- Institut für Vegetative Physiologie, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany
| | - Holger Scholz
- Institut für Vegetative Physiologie, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany.
| |
Collapse
|
2
|
Sakairi T, Abe Y, Kopp JB. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes. Nephrol Dial Transplant 2011; 26:2746-52. [PMID: 21378152 DOI: 10.1093/ndt/gfr061] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND Wilms' tumor suppressor gene (WT1) is essential for normal podocyte function, and transforming growth factor (TGF)-beta contributes to focal segmental glomerulosclerosis (FSGS). We aimed to address whether TGF-beta affects WT1 expression in podocytes. METHODS A human podocyte cell line treated with TGF-beta1 and kidneys in Alb/TGF-beta1-transgenic mice were analyzed for WT1 expression. RESULTS In cultured podocytes, TGF-beta1 reduced WT1 protein expression determined by western blotting beginning at 8 h and decreased WT1 messenger RNA (mRNA) expression measured by quantitative reverse transcription-polymerase chain reaction beginning at 3 h. Knockdown of Smad4 by small hairpin (sh) RNA partially rescued the TGF-beta1-induced reduction of both WT1 protein and mRNA expressions in the cultured podocytes. TGF-beta1 did not alter luciferase activity of the reporter construct for a human WT1 promoter but reduced that for a human WT1 5' enhancer construct, suggesting that TGF-beta1 may regulate WT1 expression by altering the 5' enhancer activity. In the transgenic mice, WT1 protein expression in podocytes was decreased at 1 and 3 weeks of age, while glomeruloclerosis developed after 3 weeks. CONCLUSION TGF-beta1 reduces WT1 expression in cultured human podocytes and podocytes in mice before overt glomerulosclerosis begins. The effects are at least partially Smad4 dependent. Our findings identify a novel pathway linking TGF-beta1 to podocyte injury and FSGS. The WT1 reduction may be a useful marker for early podocyte injury.
Collapse
Affiliation(s)
- Toru Sakairi
- Kidney Disease Section, Kidney Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
| | | | | |
Collapse
|
3
|
Scholz H, Kirschner KM. Oxygen-Dependent Gene Expression in Development and Cancer: Lessons Learned from the Wilms' Tumor Gene, WT1. Front Mol Neurosci 2011; 4:4. [PMID: 21430823 PMCID: PMC3047294 DOI: 10.3389/fnmol.2011.00004] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2011] [Accepted: 02/11/2011] [Indexed: 11/13/2022] Open
Abstract
Adequate tissue oxygenation is a prerequisite for normal development of the embryo. Most fetal organs are exquisitely susceptible to hypoxia which occurs when the delivery of oxygen is exceeded by the actual demand. Developmental abnormalities due to insufficient supply with oxygen can result from the impaired expression of genes with essential functions during embryogenesis. As such, the Wilms' tumor gene, WT1, is among the fetal genes that are regulated by the local oxygen tension. WT1 was originally discovered as a tumor suppressor gene owing to loss-of-function mutations in a subset of pediatric renal neoplasias, known as nephroblastomas or Wilms' tumors. Wilms' tumors can arise when pluripotent progenitor cells in the embryonic kidney continue to proliferate rather than differentiating to glomeruli and tubules. WT1 encodes a zinc finger protein, of which multiple isoforms exist due to alternative mRNA splicing in addition to translational and post-translational modifications. While some WT1 isoforms function as transcription factors, other WT1 proteins are presumably involved in post-transcriptional mRNA processing. However, the role of WT1 reaches far beyond that of a tumor suppressor as homozygous disruption of Wt1 in mice caused embryonic lethality with a failure of normal development of the kidneys, gonads, heart, and other tissues. WT1 mutations in humans are associated with malformation of the genitourinary system. A common paradigm of WT1 expressing cells is their capacity to switch between a mesenchymal and epithelial state. Thus, WT1 likely acts as a master switch that enables cells to undergo reciprocal epithelial-to-mesenchymal transition. Impairment of renal precursor cells to differentiate along the epithelial lineage due to WT1 mutations may favor malignant tumor growth. This article shall provide a concise review of the function of WT1 in development and disease with special consideration of its regulation by molecular oxygen.
Collapse
Affiliation(s)
- Holger Scholz
- Institut für Vegetative Physiologie, Charité - Universitätsmedizin Berlin Berlin, Germany
| | | |
Collapse
|
4
|
Bollig F, Perner B, Besenbeck B, Köthe S, Ebert C, Taudien S, Englert C. A highly conserved retinoic acid responsive element controls wt1a expression in the zebrafish pronephros. Development 2009; 136:2883-92. [PMID: 19666820 DOI: 10.1242/dev.031773] [Citation(s) in RCA: 74] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
The Wilms' tumor suppressor gene Wt1 encodes a zinc-finger transcription factor that plays an essential role in organ development, most notably of the kidney. Despite its importance for organogenesis, knowledge of the regulation of Wt1 expression is scarce. Here, we have used transgenesis in zebrafish harboring two wt1 genes, wt1a and wt1b, in order to define regulatory elements that drive wt1 expression in the kidney. Stable transgenic lines with approximately 30 kb of the upstream genomic regions of wt1a or wt1b almost exactly recapitulated endogenous expression of the wt1 paralogs. In the case of wt1b, we have identified an enhancer that is located in the far upstream region that is necessary and sufficient for reporter gene expression in the pronephric glomeruli. Regarding wt1a, we could also identify an enhancer that is located approximately 4 kb upstream of the transcriptional start site that is required for expression in the intermediate mesoderm. Interestingly, this intermediate mesoderm enhancer is highly conserved between fish and mammals, is bound by members of the retinoic acid receptor family of transcription factors in gel shift experiments and mediates responsiveness to retinoic acid both in vivo and in cell culture. To our knowledge, this is the first functional demonstration of defined regulatory elements controlling Wt1 expression in vivo. The identification of kidney-specific enhancer elements will help us to better understand the integration of extracellular signals into intracellular networks in nephrogenesis.
Collapse
Affiliation(s)
- Frank Bollig
- Molecular Genetics Group, Leibniz Institute for Age Research-Fritz Lipmann Institute, Beutenbergstrasse 11, Jena, Germany.
| | | | | | | | | | | | | |
Collapse
|
5
|
Discenza MT, Vaz D, Hassell JA, Pelletier J. Activation of the WT1 tumor suppressor gene promoter by Pea3. FEBS Lett 2004; 560:183-91. [PMID: 14988020 DOI: 10.1016/s0014-5793(04)00104-8] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2003] [Revised: 01/14/2004] [Accepted: 01/21/2004] [Indexed: 01/08/2023]
Abstract
Gene array profiling of RNA from cells engineered to express a dominant-negative version of the ETS family member transcription factor Pea3 (polyomavirus enhancer activator 3) identified WT1 as a candidate downstream gene. Given the co-expression of WT1 and Pea3 in developing kidney and breast tissue undergoing mesenchymal to epithelial transitions, we further characterized this potential gene hierarchy. Analysis of the human WT1 promoter revealed several potential binding sites for Pea3. Pea3 transactivated the WT1 promoter in transient transfection assays and bound to specific sites within the WT1 promoter in vitro. Our results position Pea3 upstream of WT1 and define a gene hierarchy important for mesenchymal-epithelial transitions.
Collapse
Affiliation(s)
- Maria Teresa Discenza
- Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, QC, Canada H3G 1Y6
| | | | | | | |
Collapse
|
6
|
Wagner KD, Wagner N, Wellmann S, Schley G, Bondke A, Theres H, Scholz H. Oxygen-regulated expression of the Wilms' tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1). FASEB J 2003; 17:1364-6. [PMID: 12738801 DOI: 10.1096/fj.02-1065fje] [Citation(s) in RCA: 85] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
The Wilms' tumor gene Wt1 is unique among tumor suppressors because of its requirement for the development of certain organs. We recently described de novo expression of Wt1 in myocardial blood vessels of ischemic rat hearts. The purpose of this study was to analyze the mechanism(s) of hypoxic/ischemic induction of Wt1. We show here that Wt1 mRNA and protein is up-regulated in the heart and kidneys of rats exposed to normobaric hypoxia (8% O2). Ectopic Wt1 immunoreactivity was detected in renal tubules of hypoxic rats, which also expressed the antiapoptotic protein Bcl-2 and contained significantly fewer TUNEL-positive cells than in normoxic kidneys. Wt1 expression was enhanced in the osteosarcoma line U-2OS and in Reh lymphoblast cells that were grown either at 1% O2 or in the presence of CoCl2 and desferrioxamine, respectively. The promoter of the Wt1 gene was capable of mediating expression of a luciferase reporter in response to hypoxia. We identified a hypoxia-responsive element in the Wt1 sequence that bound to hypoxia-inducible factor-1 (HIF-1) and was required for activation of the Wt1 promoter by CoCl2 and HIF-1. These findings demonstrate that Wt1 expression can be stimulated by hypoxia, which involves activation of the Wt1 promoter by HIF-1.
Collapse
|
7
|
Abstract
Metabolic activation of estradiol has been shown to be a key factor in endometrial carcinogenesis. 4-hydroxy estrogens (CYP1B1 metabolites) received particular attention because of their causative role in malignant transformation of various organs including endometrium. CYP1B1 displays the highest level of expression in endometrium. 4-hydroxy estrogens can bind to DNA via their quinone metabolites and cause oxidative damage in endometrial cancer. Moreover, the 4-hydroxy estrogens bind to the estrogen receptor and have estrogenic effects on target tissues. Six polymorphisms of the CYP1B1 gene have been described of which four result in amino acid substitutions; 1-13C-->T, codon 48C-->G, codon 119G-->T, codon 432C-->G, codon 449T-->C and codon 453A-->G. The polymorphisms on exons 2 and 3 have significant effects on the catalytic function of CYP1B1. Polymorphisms on specific regions of CYP1B1 gene result in hyperactivation of the protein and can lead to a higher susceptibility in the incidence of various cancers. Thus, inherited alterations in CYP1B1 hydroxylation activity may be associated with significant changes in estrogen metabolism and, thereby, may possibly explain inter-individual differences in endometrial cancer risk associated with estrogen-mediated carcinogenesis.
Collapse
Affiliation(s)
- Masahiro Sasaki
- Department of Urology (112F), University of California-San Francisco and Veterans Affairs Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA.
| | | | | | | | | |
Collapse
|
8
|
Wagner KD, Wagner N, Bondke A, Nafz B, Flemming B, Theres H, Scholz H. The Wilms' tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction. FASEB J 2002; 16:1117-9. [PMID: 12039855 DOI: 10.1096/fj.01-0986fje] [Citation(s) in RCA: 99] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Expression of the Wilms' tumor gene Wt1 in the epicardium is critical for normal heart development. Mouse embryos with inactivated Wt1 gene have extremely thin ventricles, which can result in heart failure and death. Here, we demonstrate that Wt1 can be activated in adult hearts by local ischemia. Wt1 mRNA was increased more than twofold in the left ventricular myocardium of rats between 1 day and 9 wk after infarction. Wt1 expression was localized by means of mRNA in situ hybridization and immunohistochemistry to vascular endothelial and vascular smooth muscle cells in the border zone of the infarcted tissue. A strikingly similar distribution was seen for vascular endothelial growth factor and two different cell proliferation markers in the coronary vessels of the ischemic heart. No Wt1 could be detected in the vasculature of the noninfarcted right ventricles. Wt1 expression in the coronary vessels of the ischemic heart was mimicked by exposure of rats to normobaric hypoxia (8% O2) and 0.1% CO, respectively. These findings demonstrate that Wt1 is expressed in the vasculature of the heart in response to local ischemia and hypoxia. They suggest that Wt1 has a role in the growth of coronary vessels after myocardial infarction.
Collapse
Affiliation(s)
- Kay-Dietrich Wagner
- Johannes-Müller-Institut für Physiologie and, Klinik für Innere Medizin I, Humboldt-Universität, Charité, 10117 Berlin, Germany
| | | | | | | | | | | | | |
Collapse
|
9
|
Wagner KD, Wagner N, Vidal VP, Schley G, Wilhelm D, Schedl A, Englert C, Scholz H. The Wilms' tumor gene Wt1 is required for normal development of the retina. EMBO J 2002; 21:1398-405. [PMID: 11889045 PMCID: PMC125354 DOI: 10.1093/emboj/21.6.1398] [Citation(s) in RCA: 125] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
The Wilms' tumor gene Wt1 is known for its important functions during genitourinary and mesothelial formation. Here we show that Wt1 is necessary for neuronal development in the vertebrate retina. Mouse embryos with targeted disruption of Wt1 exhibit remarkably thinner retinas than age-matched wild-type animals. A large fraction of retinal ganglion cells is lost by apoptosis, and the growth of optic nerve fibers is severely disturbed. Strikingly, expression of the class IV POU-domain transcription factor Pou4f2 (formerly Brn-3b), which is critical for the survival of most retinal ganglion cells, is lost in Wt1(-/-) retinas. Forced expression of Wt1 in cultured cells causes an up-regulation of Pou4f2 mRNA. Moreover, the Wt1(-KTS) splice variant can activate a reporter construct carrying 5'-regulatory sequences of the human POU4F2. The lack of Pou4f2 and the ocular defects in Wt1(-/-) embryos are rescued by transgenic expression of a 280 kb yeast artificial chromosome carrying the human WT1 gene. Taken together, our findings demonstrate a continuous requirement for Wt1 in normal retina formation with a critical role in Pou4f2-dependent ganglion cell differentiation.
Collapse
Affiliation(s)
- Kay-Dietrich Wagner
- Johannes-Müller-Institut für Physiologie and Medizinische Klinik I, Medizinische Fakultät Charité, Humboldt-Universität, Berlin, Developmental Genetics Group, Max-Delbrück Center for Molecular Medicine (MDC), Berlin-Buch and Forschungszentrum Karlsruhe, Institut für Toxikologie und Genetik, Karlsruhe, Germany Present address: University of Newcastle, Human Molecular Genetics Unit, Newcastle upon Tyne NE1 7RU, UK Present address: EPIDAUROS Biotechnologie AG, Am Neuland 1, D-82347 Bernried, Germany Corresponding author e-mail: K.-D.Wagner and N.Wagner contributed equally to this work
| | - Nicole Wagner
- Johannes-Müller-Institut für Physiologie and Medizinische Klinik I, Medizinische Fakultät Charité, Humboldt-Universität, Berlin, Developmental Genetics Group, Max-Delbrück Center for Molecular Medicine (MDC), Berlin-Buch and Forschungszentrum Karlsruhe, Institut für Toxikologie und Genetik, Karlsruhe, Germany Present address: University of Newcastle, Human Molecular Genetics Unit, Newcastle upon Tyne NE1 7RU, UK Present address: EPIDAUROS Biotechnologie AG, Am Neuland 1, D-82347 Bernried, Germany Corresponding author e-mail: K.-D.Wagner and N.Wagner contributed equally to this work
| | - Valerie P.I. Vidal
- Johannes-Müller-Institut für Physiologie and Medizinische Klinik I, Medizinische Fakultät Charité, Humboldt-Universität, Berlin, Developmental Genetics Group, Max-Delbrück Center for Molecular Medicine (MDC), Berlin-Buch and Forschungszentrum Karlsruhe, Institut für Toxikologie und Genetik, Karlsruhe, Germany Present address: University of Newcastle, Human Molecular Genetics Unit, Newcastle upon Tyne NE1 7RU, UK Present address: EPIDAUROS Biotechnologie AG, Am Neuland 1, D-82347 Bernried, Germany Corresponding author e-mail: K.-D.Wagner and N.Wagner contributed equally to this work
| | - Gunnar Schley
- Johannes-Müller-Institut für Physiologie and Medizinische Klinik I, Medizinische Fakultät Charité, Humboldt-Universität, Berlin, Developmental Genetics Group, Max-Delbrück Center for Molecular Medicine (MDC), Berlin-Buch and Forschungszentrum Karlsruhe, Institut für Toxikologie und Genetik, Karlsruhe, Germany Present address: University of Newcastle, Human Molecular Genetics Unit, Newcastle upon Tyne NE1 7RU, UK Present address: EPIDAUROS Biotechnologie AG, Am Neuland 1, D-82347 Bernried, Germany Corresponding author e-mail: K.-D.Wagner and N.Wagner contributed equally to this work
| | - Dagmar Wilhelm
- Johannes-Müller-Institut für Physiologie and Medizinische Klinik I, Medizinische Fakultät Charité, Humboldt-Universität, Berlin, Developmental Genetics Group, Max-Delbrück Center for Molecular Medicine (MDC), Berlin-Buch and Forschungszentrum Karlsruhe, Institut für Toxikologie und Genetik, Karlsruhe, Germany Present address: University of Newcastle, Human Molecular Genetics Unit, Newcastle upon Tyne NE1 7RU, UK Present address: EPIDAUROS Biotechnologie AG, Am Neuland 1, D-82347 Bernried, Germany Corresponding author e-mail: K.-D.Wagner and N.Wagner contributed equally to this work
| | - Andreas Schedl
- Johannes-Müller-Institut für Physiologie and Medizinische Klinik I, Medizinische Fakultät Charité, Humboldt-Universität, Berlin, Developmental Genetics Group, Max-Delbrück Center for Molecular Medicine (MDC), Berlin-Buch and Forschungszentrum Karlsruhe, Institut für Toxikologie und Genetik, Karlsruhe, Germany Present address: University of Newcastle, Human Molecular Genetics Unit, Newcastle upon Tyne NE1 7RU, UK Present address: EPIDAUROS Biotechnologie AG, Am Neuland 1, D-82347 Bernried, Germany Corresponding author e-mail: K.-D.Wagner and N.Wagner contributed equally to this work
| | - Christoph Englert
- Johannes-Müller-Institut für Physiologie and Medizinische Klinik I, Medizinische Fakultät Charité, Humboldt-Universität, Berlin, Developmental Genetics Group, Max-Delbrück Center for Molecular Medicine (MDC), Berlin-Buch and Forschungszentrum Karlsruhe, Institut für Toxikologie und Genetik, Karlsruhe, Germany Present address: University of Newcastle, Human Molecular Genetics Unit, Newcastle upon Tyne NE1 7RU, UK Present address: EPIDAUROS Biotechnologie AG, Am Neuland 1, D-82347 Bernried, Germany Corresponding author e-mail: K.-D.Wagner and N.Wagner contributed equally to this work
| | - Holger Scholz
- Johannes-Müller-Institut für Physiologie and Medizinische Klinik I, Medizinische Fakultät Charité, Humboldt-Universität, Berlin, Developmental Genetics Group, Max-Delbrück Center for Molecular Medicine (MDC), Berlin-Buch and Forschungszentrum Karlsruhe, Institut für Toxikologie und Genetik, Karlsruhe, Germany Present address: University of Newcastle, Human Molecular Genetics Unit, Newcastle upon Tyne NE1 7RU, UK Present address: EPIDAUROS Biotechnologie AG, Am Neuland 1, D-82347 Bernried, Germany Corresponding author e-mail: K.-D.Wagner and N.Wagner contributed equally to this work
| |
Collapse
|
10
|
Vidal VP, Chaboissier MC, de Rooij DG, Schedl A. Sox9 induces testis development in XX transgenic mice. Nat Genet 2001; 28:216-7. [PMID: 11431689 DOI: 10.1038/90046] [Citation(s) in RCA: 514] [Impact Index Per Article: 22.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Mutations in SOX9 are associated with male-to-female sex reversal in humans. To analyze Sox9 function during sex determination, we ectopically expressed this gene in XX gonads. Here, we show that Sox9 is sufficient to induce testis formation in mice, indicating that it can substitute for the sex-determining gene Sry.
Collapse
Affiliation(s)
- V P Vidal
- MDC for Molecular Medicine, Robert-Rössle-Strasse 10, 13092 Berlin, Germany
| | | | | | | |
Collapse
|
11
|
Wagner KD, Wagner N, Sukhatme VP, Scholz H. Activation of Vitamin D Receptor by the Wilms' Tumor GeneProduct Mediates Apoptosis of Renal Cells. J Am Soc Nephrol 2001; 12:1188-1196. [PMID: 11373341 DOI: 10.1681/asn.v1261188] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Abstract. The Wilms' tumor transcription factor WT1 is required for kidney development, but little is known about WT1 downstream signaling in renal cells. This study reported an approximately fivefold upregulation of vitamin D receptor (VDR) mRNA and protein in human embryonic kidney (HEK) 293 cells that stably expressed WT1 at a level comparable to the developing kidney in vivo. Co-transfection of HEK 293 cells with expression plasmids encoding four different WT1 splicing variants stimulated mouse vdr promoter activity more than fourfold. A 201-bp fragment was identified in the proximal vdr promoter that was required for transactivation by WT1. This critical sequence contained a predicted WT1 consensus site, which bound to recombinant WT1 protein. Temporal changes of vdr and wt1 mRNA levels in developing rat kidneys were correlated closely. The active metabolite 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) strongly inhibited the proliferation of wt1-transfected HEK 293 cells. Exposure to 1,25-(OH)2D3 caused apoptosis of cultured wt1 immunopositive cells from mouse embryonic kidney cortex. These findings suggest that transcriptional activation of the VDR by WT1 can mediate programmed death of renal embryonic cells in response to 1,25-(OH)2D3. The results provide the first evidence for a role of the vitamin D endocrine system in renal cell growth and differentiation during development.
Collapse
Affiliation(s)
- Kay-Dietrich Wagner
- Johannes-Müller-Institut für Physiologie, Humboldt-Universität, Charité, Berlin, Germany
| | - Nicole Wagner
- Klinik für Innere Medizin I, Humboldt-Universität, Charité, Berlin, Germany
| | - Vikas P Sukhatme
- Beth Israel Deaconess Medical Center, Renal Division, Boston, Massachusetts
| | - Holger Scholz
- Johannes-Müller-Institut für Physiologie, Humboldt-Universität, Charité, Berlin, Germany
| |
Collapse
|
12
|
Gawin B, Niederführ A, Schumacher N, Hummerich H, Little PF, Gessler M. A 7.5 Mb sequence-ready PAC contig and gene expression map of human chromosome 11p13-p14.1. Genome Res 1999; 9:1074-86. [PMID: 10568747 PMCID: PMC310838 DOI: 10.1101/gr.9.11.1074] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
The region p13 of the short arm of human chromosome 11 has been studied intensely during the search for genes involved in the etiology of the Wilms' tumor, aniridia, genitourinary abnormalities, mental retardation (WAGR) syndrome, and related conditions. The gene map for this region is far from being complete, however, strengthening the need for additional gene identification efforts. We describe the extension of an existing contig map with P1-derived artificial chromosomes (PACs) to cover 7.5 Mb of 11p13-14.1. The extended sequence-ready contig was established by end probe walking and fingerprinting and consists of 201 PAC clones. Utilizing bins defined by overlapping PACs, we generated a detailed gene map containing 20 genes as well as 22 anonymous ESTs which have been identified by searching the RH databases. RH maps and our established gene map show global correlation, but the limits of resolution of the current RH panels are evident at this scale. Initial expression studies on the novel genes have been performed by Northern blot analyses. To extend these expression profiles, corresponding mouse cDNA clones were identified by database search and employed for Northern blot analyses and RNA in situ hybridizations to mouse embryo sections. Genomic sequencing of clones along a minimal tiling path through the contig is currently under way and will facilitate these expression studies by in silico gene identification approaches.
Collapse
Affiliation(s)
- B Gawin
- Physiologische Chemie I, Biozentrum der Universität Würzburg, Germany
| | | | | | | | | | | |
Collapse
|
13
|
Abstract
The past 2 years have provided exciting progress in elucidating the molecular basis of renal cancer. Work on the von Hippel-Lindau tumor suppressor, pVHL, in clear-cell renal cancer is already suggesting new potential therapies, and should have important implications in the pathogenesis of renal cystic disease and tumor angiogenesis. In addition, study of the Wilms' tumor suppressor, WT1, is revealing much about the pathogenesis of Wilms' tumor, urogenital development, and glomerular podocyte biology. c-met, the gene encoding the hepatocyte growth factor receptor, has recently been identified as a causative gene for hereditary papillary renal cancer. This review will highlight these and other new molecular advances in the renal cancer field.
Collapse
Affiliation(s)
- H T Cohen
- Department of Medicine, Boston University Medical Center, MA 02118, USA.
| |
Collapse
|
14
|
Moore AW, Schedl A, McInnes L, Doyle M, Hecksher-Sorensen J, Hastie ND. YAC transgenic analysis reveals Wilms' tumour 1 gene activity in the proliferating coelomic epithelium, developing diaphragm and limb. Mech Dev 1998; 79:169-84. [PMID: 10349631 DOI: 10.1016/s0925-4773(98)00188-9] [Citation(s) in RCA: 113] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Wilms' Tumour 1 gene (WT1) is required for the correct development of the urogenital system. To examine its regulation and expression, we created several transgenic mouse lines containing a beta-galactosidase reporter driven by the human WT1 promoter. A 5 kb promoter weakly recapitulated a subset of the endogenous Wt1 expression pattern. In contrast, 470 and 280 kb YAC transgenes reproduced the correct pattern with high activity and highlighted new expression sites. Wt1 is expressed in the septum transversum revealing how its mutation causes diaphragmatic defects. Wt1 expression in the limb demarcates a zone between chondrogenic and apoptotic domains. Finally, Wt1 is expressed in mesenchymal cells derived from the coelomic epithelium. Based upon these and further data we discuss a Wt1 role in epithelial<-->mesenchymal transitions.
Collapse
Affiliation(s)
- A W Moore
- MRC Human Genetics Unit, Western General Hospital, Edinburg, UK
| | | | | | | | | | | |
Collapse
|
15
|
Niederführ A, Hummerich H, Gawin B, Boyle S, Little PF, Gessler M. A sequence-ready 3-Mb PAC contig covering 16 breakpoints of the Wilms tumor/anirida region of human chromosome 11p13. Genomics 1998; 53:155-63. [PMID: 9790764 DOI: 10.1006/geno.1998.5486] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
A large body of evidence that links alterations of chromosome 11p13 to tumor formation and various developmental disorders has been accumulated. To address the underlying genetic events it would be helpful to have a comprehensive gene map of the region, and this is most readily achieved by generating the complete genomic sequence. Building upon previous mapping and YAC contig analysis we have established a 3-Mb sequence-ready PAC contig. It was constructed by chromosome walking and independently verified by fingerprint analysis of individual clones. The contig starts from the catalase gene on the centromeric side and reaches beyond the PAX6 gene at the 11p13/p14.1 boundary. Additional smaller contigs on either side were identified, but still have to be linked up. The 3-Mb contig spans the central region of deletions encompassing 16 chromosomal breakpoints in patients with WAGR syndrome (Wilms tumor, aniridia, genitourinary malformation, mental retardation), and its construction is an important step in facilitating functional analysis of these genes.
Collapse
Affiliation(s)
- A Niederführ
- Physiologische Chemie I, Theodor-Boveri-Institut für Biowissenschaften der Universität Würzburg, Am Hubland, Würzburg, D-97074, Germany
| | | | | | | | | | | |
Collapse
|
16
|
Abstract
The Wilms tumor-suppressor gene WT1 was originally identified through its involvement in the development of a pediatric kidney tumor. Recent genetic data show that mutations in the WT1 gene cause a variety of other diseases, and new biochemical evidence suggests that the WT1 protein is not only a transcription factor but might also act at the post-transcriptional level.
Collapse
Affiliation(s)
- C Englert
- Research Center Karlsruhe, Institute of Genetics, Karlsruhe, Germany.
| |
Collapse
|